Sandoz, Teva and Viatris are navigating generic drug pricing pressure with scale, complex generics and cost cuts.

Health Affairs' Rob Lott interviews Keith Drake of Greylock McKinnon Associates about his recent paper that explores trends ...

Patent settlements accelerate the entry of generics and biosimilars, saving the health care system $422.9 billion and ...

President Trump issued Executive Order 14297 targeting prescription drug prices in America. The stated purpose of this order is ...

Another factor is patent exclusivity. Over the years, U.S. pharmaceutical companies have used strong legal protections to amass patents that can keep generic competitors from the marketplace. Drug ...

Amgen is no exception to this dynamic. Although 2017's Tax Cuts and Jobs Act spurred the company to build a handful of new manufacturing sites within the U.S., it's still heavily reliant on its ...

These schemes are aimed at protecting and encouraging domestic ingredient manufacturing which is seen as a critical step in ...

Prescription drugs prices have rapidly increased, but opting for generic medications and incorporating lifestyle changes are some ways to cut costs.